Home > News > Industry news > FDA Permits Marketing of First Anal Inte…

FDA Permits Marketing of First Anal Intercourse Condom

U.S. Food and Drug Administration authorized the marketing of the first condoms specifically indicated to help reduce transmission of sexually transmitted infections (STIs) during the anal intercourse. The condoms, which will be marketed as the One brand Male Condom, are also indicated as a contraceptive to help reduce risk of pregnancy and the transmission of STIs during the vaginal intercourse.

Before the authorization, FDA had not cleared or approved any condoms specifically indicated for anal intercourse. Unprotected anal intercourse carries the greatest sexual exposure risk of HIV transmission. Consistent and correct condom use has the potential to significantly help decrease the risk of STIs. While today’s authorization underscores the public health importance of condoms tested and labeled specifically for anal intercourse, all other FDA-cleared condoms can continue to be used for contraception and STI prevention. It’s important to continue to use condoms consistently and correctly to reduce the risk of STI transmission, including HIV, and to prevent pregnancy.

Original news from the link from FDA, Please visit the original news: https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-first-condom-specifically-indicated-anal-intercourse

Scan the qr codeClose
the qr code